Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
OBI-3424
i
Other names:
OBI-3424, OBI 3424, TH-3424, OBI3424, TH3424, TH 3424, AST-3424
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Ascentawits Pharma, OBI Pharma
Drug class:
Alkylating agent
Related drugs:
‹
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
procarbazine hydrochloride (4)
D19466 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
LP-284 (2)
fotemustine (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
procarbazine hydrochloride (4)
D19466 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
LP-284 (2)
fotemustine (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
AKR1C3 overexpression
Pancreatic Cancer
AKR1C3 overexpression
Pancreatic Cancer
OBI-3424
Sensitive: C3 – Early Trials
OBI-3424
Sensitive
:
C3
OBI-3424
Sensitive: C3 – Early Trials
OBI-3424
Sensitive
:
C3
AKR1C3 overexpression
Hepatocellular Cancer
AKR1C3 overexpression
Hepatocellular Cancer
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
BRCA2 mutation + AKR1C3 overexpression
Pancreatic Cancer
BRCA2 mutation + AKR1C3 overexpression
Pancreatic Cancer
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
BRCA1 mutation + AKR1C3 overexpression
Pancreatic Cancer
BRCA1 mutation + AKR1C3 overexpression
Pancreatic Cancer
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
OBI-3424
Sensitive: D – Preclinical
OBI-3424
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login